 Heather Fairfield
Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Myeloma | 11 | 2025 | 282 | 2.520 |
Why?
| | Bone Marrow | 9 | 2023 | 301 | 1.540 |
Why?
| | Adipocytes | 4 | 2021 | 220 | 1.320 |
Why?
| | Adipose Tissue | 4 | 2020 | 645 | 1.300 |
Why?
| | Bone Marrow Cells | 3 | 2020 | 326 | 1.190 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 71 | 0.830 |
Why?
| | Exome | 4 | 2016 | 238 | 0.790 |
Why?
| | Osteocytes | 2 | 2017 | 30 | 0.660 |
Why?
| | Models, Biological | 3 | 2018 | 1822 | 0.620 |
Why?
| | Cellular Senescence | 1 | 2020 | 206 | 0.570 |
Why?
| | Mutation | 8 | 2022 | 3999 | 0.560 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.520 |
Why?
| | Tumor Microenvironment | 4 | 2023 | 699 | 0.510 |
Why?
| | Glycoproteins | 1 | 2017 | 358 | 0.460 |
Why?
| | DNA Mutational Analysis | 3 | 2013 | 396 | 0.370 |
Why?
| | Mice | 22 | 2023 | 18057 | 0.370 |
Why?
| | Cancellous Bone | 2 | 2021 | 26 | 0.320 |
Why?
| | Genomics | 2 | 2015 | 810 | 0.320 |
Why?
| | Monoclonal Gammopathy of Undetermined Significance | 2 | 2023 | 11 | 0.320 |
Why?
| | Phenotype | 6 | 2020 | 3172 | 0.310 |
Why?
| | Osteogenesis | 3 | 2021 | 198 | 0.300 |
Why?
| | Animals | 26 | 2023 | 37579 | 0.300 |
Why?
| | Mice, Inbred C57BL | 9 | 2021 | 5895 | 0.290 |
Why?
| | Neoplasm Proteins | 2 | 2023 | 433 | 0.260 |
Why?
| | Spermatogenesis | 2 | 2019 | 69 | 0.250 |
Why?
| | Stem Cell Niche | 2 | 2017 | 58 | 0.240 |
Why?
| | Coenzyme A Ligases | 1 | 2025 | 15 | 0.230 |
Why?
| | Genetic Diseases, Inborn | 2 | 2015 | 47 | 0.210 |
Why?
| | INDEL Mutation | 2 | 2014 | 17 | 0.200 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2604 | 0.200 |
Why?
| | Mice, SCID | 2 | 2020 | 365 | 0.200 |
Why?
| | Nails, Malformed | 1 | 2022 | 7 | 0.200 |
Why?
| | Nail Diseases | 1 | 2022 | 9 | 0.190 |
Why?
| | Adiposity | 2 | 2017 | 518 | 0.190 |
Why?
| | Cell Cycle | 2 | 2023 | 598 | 0.170 |
Why?
| | Enzyme Inhibitors | 1 | 2025 | 842 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2021 | 78 | 0.170 |
Why?
| | Antibodies, Neutralizing | 2 | 2020 | 321 | 0.170 |
Why?
| | 3T3-L1 Cells | 2 | 2017 | 36 | 0.170 |
Why?
| | 3T3 Cells | 1 | 2020 | 154 | 0.170 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3487 | 0.160 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2019 | 139 | 0.160 |
Why?
| | Fatty Acids | 1 | 2023 | 448 | 0.160 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2020 | 42 | 0.160 |
Why?
| | Coculture Techniques | 1 | 2020 | 244 | 0.160 |
Why?
| | Receptors, IgG | 1 | 2020 | 77 | 0.160 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 8 | 0.150 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2020 | 170 | 0.150 |
Why?
| | Spermatogonia | 1 | 2019 | 14 | 0.150 |
Why?
| | Frameshift Mutation | 2 | 2016 | 32 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2017 | 438 | 0.150 |
Why?
| | Cell Communication | 1 | 2020 | 316 | 0.150 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 102 | 0.140 |
Why?
| | Silk | 1 | 2018 | 2 | 0.140 |
Why?
| | Dexamethasone | 1 | 2020 | 379 | 0.140 |
Why?
| | Mitochondria | 1 | 2025 | 974 | 0.140 |
Why?
| | Obesity | 3 | 2023 | 3000 | 0.140 |
Why?
| | Bone and Bones | 2 | 2021 | 313 | 0.140 |
Why?
| | Genetic Linkage | 2 | 2015 | 288 | 0.140 |
Why?
| | Cortical Bone | 1 | 2017 | 19 | 0.140 |
Why?
| | Biopsy | 1 | 2020 | 1069 | 0.130 |
Why?
| | Culture Media, Conditioned | 1 | 2017 | 112 | 0.130 |
Why?
| | Alleles | 4 | 2016 | 883 | 0.130 |
Why?
| | Paracrine Communication | 1 | 2017 | 66 | 0.130 |
Why?
| | Mutation, Missense | 2 | 2016 | 340 | 0.130 |
Why?
| | Disease Progression | 2 | 2023 | 2791 | 0.130 |
Why?
| | Gray Platelet Syndrome | 1 | 2016 | 4 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2020 | 467 | 0.120 |
Why?
| | Gonadal Steroid Hormones | 1 | 2017 | 138 | 0.120 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 18 | 0.120 |
Why?
| | Base Pairing | 1 | 2016 | 64 | 0.120 |
Why?
| | Leptin | 1 | 2017 | 238 | 0.120 |
Why?
| | Apoptosis | 2 | 2025 | 2571 | 0.120 |
Why?
| | Hyperpigmentation | 1 | 2016 | 27 | 0.120 |
Why?
| | Antibodies, Monoclonal | 2 | 2020 | 1471 | 0.120 |
Why?
| | Gene Expression | 1 | 2020 | 1490 | 0.120 |
Why?
| | Tissue Scaffolds | 1 | 2018 | 213 | 0.120 |
Why?
| | Maxillofacial Development | 1 | 2015 | 20 | 0.120 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 389 | 0.120 |
Why?
| | Bone Remodeling | 1 | 2016 | 76 | 0.120 |
Why?
| | Proteomics | 2 | 2023 | 1136 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 832 | 0.120 |
Why?
| | Keratoderma, Palmoplantar | 1 | 2015 | 6 | 0.110 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 202 | 0.110 |
Why?
| | Hair Diseases | 1 | 2015 | 10 | 0.110 |
Why?
| | Desmoplakins | 1 | 2015 | 27 | 0.110 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 75 | 0.110 |
Why?
| | Osteoblasts | 3 | 2021 | 136 | 0.110 |
Why?
| | Hydronephrosis | 1 | 2015 | 36 | 0.110 |
Why?
| | Pyrophosphatases | 1 | 2014 | 26 | 0.110 |
Why?
| | Transplantation, Autologous | 1 | 2016 | 280 | 0.110 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2014 | 50 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 544 | 0.110 |
Why?
| | Tumor Burden | 1 | 2016 | 310 | 0.110 |
Why?
| | Organogenesis | 1 | 2015 | 61 | 0.110 |
Why?
| | Stem Cell Transplantation | 1 | 2016 | 187 | 0.110 |
Why?
| | Exons | 2 | 2016 | 352 | 0.110 |
Why?
| | Hair | 1 | 2015 | 89 | 0.110 |
Why?
| | Urogenital Abnormalities | 1 | 2015 | 71 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 873 | 0.110 |
Why?
| | Blood Proteins | 1 | 2016 | 250 | 0.100 |
Why?
| | Mice, Inbred Strains | 2 | 2011 | 412 | 0.100 |
Why?
| | Humans | 16 | 2025 | 140898 | 0.100 |
Why?
| | Metformin | 1 | 2017 | 329 | 0.100 |
Why?
| | Tissue Engineering | 1 | 2018 | 429 | 0.100 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2013 | 37 | 0.100 |
Why?
| | Genetic Association Studies | 1 | 2015 | 375 | 0.100 |
Why?
| | Infertility, Male | 1 | 2013 | 61 | 0.100 |
Why?
| | NADPH Oxidases | 2 | 2010 | 140 | 0.100 |
Why?
| | Vascular Calcification | 1 | 2014 | 111 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 495 | 0.100 |
Why?
| | Lipids | 1 | 2018 | 689 | 0.100 |
Why?
| | Bone Diseases | 1 | 2013 | 66 | 0.100 |
Why?
| | Infertility, Female | 1 | 2013 | 107 | 0.100 |
Why?
| | Cytokines | 1 | 2020 | 2092 | 0.100 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1485 | 0.090 |
Why?
| | Fractures, Bone | 1 | 2017 | 406 | 0.090 |
Why?
| | Chromosomes, Mammalian | 1 | 2011 | 28 | 0.090 |
Why?
| | Female | 9 | 2021 | 75540 | 0.090 |
Why?
| | Collagen Type II | 1 | 2011 | 55 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 433 | 0.090 |
Why?
| | Indicators and Reagents | 1 | 2011 | 110 | 0.090 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2011 | 71 | 0.090 |
Why?
| | Male | 9 | 2019 | 69893 | 0.090 |
Why?
| | Cardiomyopathies | 1 | 2015 | 331 | 0.090 |
Why?
| | Ear, Inner | 1 | 2010 | 52 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2011 | 504 | 0.080 |
Why?
| | Gene Frequency | 1 | 2011 | 492 | 0.080 |
Why?
| | Mice, Knockout | 1 | 2017 | 3064 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5789 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 994 | 0.080 |
Why?
| | Aging | 1 | 2020 | 1917 | 0.080 |
Why?
| | Phagocytes | 1 | 2010 | 103 | 0.080 |
Why?
| | Cell Survival | 2 | 2025 | 1129 | 0.080 |
Why?
| | Genotype | 2 | 2011 | 1862 | 0.080 |
Why?
| | Multiprotein Complexes | 1 | 2010 | 171 | 0.070 |
Why?
| | Transcription Factors | 2 | 2015 | 1703 | 0.070 |
Why?
| | Terminal Repeat Sequences | 1 | 2008 | 18 | 0.070 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 2008 | 45 | 0.070 |
Why?
| | Genome-Wide Association Study | 1 | 2015 | 1403 | 0.070 |
Why?
| | Prolactin | 1 | 2008 | 92 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4407 | 0.070 |
Why?
| | Genetic Markers | 2 | 2019 | 342 | 0.070 |
Why?
| | Kidney | 1 | 2015 | 1475 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3336 | 0.060 |
Why?
| | Progesterone | 1 | 2008 | 258 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2017 | 99 | 0.060 |
Why?
| | Base Sequence | 3 | 2016 | 2169 | 0.060 |
Why?
| | Antibodies | 2 | 2019 | 411 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2016 | 2917 | 0.060 |
Why?
| | Triazenes | 1 | 2025 | 6 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2025 | 2497 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2156 | 0.050 |
Why?
| | Proteins | 1 | 2010 | 1013 | 0.050 |
Why?
| | Cyclobutanes | 1 | 2023 | 7 | 0.050 |
Why?
| | Dicarboxylic Acids | 1 | 2023 | 12 | 0.050 |
Why?
| | Growth and Development | 1 | 2022 | 9 | 0.050 |
Why?
| | Nails | 1 | 2022 | 13 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1726 | 0.050 |
Why?
| | Horses | 1 | 2022 | 200 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 184 | 0.040 |
Why?
| | Teriparatide | 1 | 2019 | 9 | 0.040 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2019 | 25 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 54 | 0.040 |
Why?
| | Testis | 1 | 2019 | 158 | 0.040 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 111 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2017 | 43 | 0.030 |
Why?
| | Dihydrotestosterone | 1 | 2017 | 44 | 0.030 |
Why?
| | Androgen Receptor Antagonists | 1 | 2017 | 35 | 0.030 |
Why?
| | Cell Count | 1 | 2017 | 325 | 0.030 |
Why?
| | Diphosphonates | 1 | 2017 | 69 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2017 | 265 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 477 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 189 | 0.030 |
Why?
| | Emperipolesis | 1 | 2016 | 1 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 2016 | 13 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2017 | 250 | 0.030 |
Why?
| | Imidazoles | 1 | 2017 | 254 | 0.030 |
Why?
| | Osteopetrosis | 1 | 2015 | 2 | 0.030 |
Why?
| | Tooth Eruption | 1 | 2015 | 10 | 0.030 |
Why?
| | Cephalometry | 1 | 2015 | 31 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 453 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2016 | 187 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 956 | 0.030 |
Why?
| | Neutropenia | 1 | 2016 | 154 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 545 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 363 | 0.030 |
Why?
| | Fertility | 1 | 2016 | 165 | 0.030 |
Why?
| | Stem Cells | 1 | 2019 | 603 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 158 | 0.030 |
Why?
| | Skull | 1 | 2015 | 147 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 568 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 740 | 0.030 |
Why?
| | Thrombocytopenia | 1 | 2016 | 207 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 525 | 0.030 |
Why?
| | Spleen | 1 | 2016 | 522 | 0.030 |
Why?
| | Chromosome Pairing | 1 | 2013 | 7 | 0.030 |
Why?
| | Face | 1 | 2015 | 175 | 0.030 |
Why?
| | Estradiol | 1 | 2017 | 523 | 0.030 |
Why?
| | Body Composition | 1 | 2017 | 703 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2522 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2014 | 137 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2013 | 306 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2015 | 310 | 0.020 |
Why?
| | Point Mutation | 1 | 2013 | 237 | 0.020 |
Why?
| | Genetic Loci | 1 | 2013 | 276 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 702 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2152 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 817 | 0.020 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2015 | 340 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 566 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 1999 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1968 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5594 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1282 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4199 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2010 | 147 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 720 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 336 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1190 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 985 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2128 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2008 | 87 | 0.020 |
Why?
| | Mammary Glands, Human | 1 | 2008 | 66 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 632 | 0.020 |
Why?
| | Drug Synergism | 1 | 2008 | 369 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 188 | 0.020 |
Why?
| | Transfection | 1 | 2008 | 936 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2010 | 2176 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2760 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2238 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2008 | 2235 | 0.010 |
Why?
|
|
Fairfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|